We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nutrien's Q4 Earnings and Revenues Lag Estimates, Decline Y/Y
Read MoreHide Full Article
Nutrien Ltd. (NTR - Free Report) recorded fourth-quarter 2024 profits of $118 million or 23 cents per share, down from $176 million or 35 cents per share in the year-ago quarter.
Barring one-time items, adjusted earnings per share were 31 cents. The bottom line missed the Zacks Consensus Estimate of 33 cents.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Sales tumbled around 10.3% year over year to $5,079 million in the quarter. Nevertheless, the figure missed the Zacks Consensus Estimate of $5,151.9 million.
The decline in earnings is primarily due to reduced potash net selling prices and sales volumes, which were slightly offset by greater Retail segment earnings and lower expenses.
Sales in the Nutrien Ag Solutions (Retail) segment declined 9% year over year to $3,179 million. Retail adjusted EBITDA for the segment increased as a result of lower expenses and higher crop protection and seed margins, including enhanced proprietary product gross margins and improved margins and selling expenses in Brazil. The figure was higher than our estimate of $3,113.2 million.
The Potash division’s sales declined 31% year over year to $536 million, lower than our estimate of $709 million. Potash sales volumes fell from the previous year's record levels, owing to a more restricted fall application window in North America and fewer exports to China and other Asian countries.
Sales in the Nitrogen segment were $1,013 million, up around 6% year over year. Nitrogen sales volumes grew in the fourth quarter, owing to increasing urea production and robust regional demand for ammonia. Sales volumes grew for the full year 2024 primarily due to increased production at NTR’s Trinidad operations and reliability improvements across the North American network, which boosted the availability of upgraded products. The reported figure was lower than our estimate of $1,033.8 million.
Sales in the Phosphate segment were $414 million, down around 22% year over year. The figure was higher than our estimate of $360.1 million. Phosphate sales volumes fell in the fourth quarter and 2024, owing mostly to weather-related incidents and plant outages that reduced output volumes.
NTR’s Financials
At the end of the quarter, Nutrien had cash and cash equivalents of $853 million, down around 9.3% year over year. Long-term debt was $8,881 million, down nearly 0.3% year over year.
Cash provided by operating activities was $3,123 million in the quarter.
NTR’s FY24 Results
Nutrien reported net earnings of $1.36 earnings per share compared with $2.53 a year ago. Adjusted earnings per share were $3.47 compared with $4.44 a year ago. The company recorded total sales of around $26 billion for the year (down 11% year over year), with adjusted EBITDA reaching roughly $5.4 billion.
NTR’s Guidance
Nutrien projects Retail adjusted EBITDA in the range of $1.65-$1.85 billion for 2025. The company anticipates increased crop nutrient sales volumes, ongoing expansion of its proprietary products and additional margin recovery in Brazil. It anticipates foreign exchange headwinds in its international retail operations, as well as the lack of asset sales and other income items recognized in 2024, totaling about $75 million.
The projected potash sales volume range of 13.6-14.4 million tons is consistent with its global shipments outlook and takes into consideration some uncertainty about the potential imposition and impact of U.S. tariffs, as well as global supply availability.
Nitrogen sales volume projection of 10.7-11.2 million tons is based on sustained reliability improvements and increased operating rates at NTR’s North American operations.
The phosphate sales volume projection of 2.35-2.55 million tons implies reduced production at the company’s White Springs facility in the first half of 2025 and higher operating rates in the second half compared with the previous year.
Total capital expenditures of $2- $2.1 billion are projected to be lower than last year.
NTR’s Stock Price Performance
Nutrien’s shares have lost 1.9% in the past year compared with the industry’s 2.4% decline.
Image Source: Zacks Investment Research
NTR’s Zacks Rank & Key Picks
NTR currently carries a Zacks Rank #3 (Hold).
Better-ranked stocks worth a look in the basic materials space are ICL Group Ltd. (ICL - Free Report) , Fortuna Mining Corp. (FSM - Free Report) and Kronos Worldwide (KRO - Free Report) .
ICL is slated to report fourth-quarter results on Feb. 26. The Zacks Consensus Estimate for fourth-quarter earnings is pegged at six cents per share. ICL beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 18.1%. ICL currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Fortuna is scheduled to release fourth-quarter results on March 5. The Zacks Consensus Estimate for FSM’s fourth-quarter earnings is pegged at 16 cents per share. FSM, a Zacks Rank #2 stock, has gained around 64.6% in the past year. FSM beat the Zacks Consensus Estimate in two of the last four quarters while missing twice, with the average earnings surprise being 53.5%.
Kronos is expected to report fourth-quarter results on March 5. The consensus estimate for KRO’s fourth-quarter earnings is pegged at 11 cents per share. KRO, carrying a Zacks Rank of 2 at present, beat the consensus estimate in three of the last four quarters while missing once, with the average earnings surprise being 41.7%.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Nutrien's Q4 Earnings and Revenues Lag Estimates, Decline Y/Y
Nutrien Ltd. (NTR - Free Report) recorded fourth-quarter 2024 profits of $118 million or 23 cents per share, down from $176 million or 35 cents per share in the year-ago quarter.
Barring one-time items, adjusted earnings per share were 31 cents. The bottom line missed the Zacks Consensus Estimate of 33 cents.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Sales tumbled around 10.3% year over year to $5,079 million in the quarter. Nevertheless, the figure missed the Zacks Consensus Estimate of $5,151.9 million.
The decline in earnings is primarily due to reduced potash net selling prices and sales volumes, which were slightly offset by greater Retail segment earnings and lower expenses.
Nutrien Ltd. Price, Consensus and EPS Surprise
Nutrien Ltd. price-consensus-eps-surprise-chart | Nutrien Ltd. Quote
NTR’s Segment Highlights
Sales in the Nutrien Ag Solutions (Retail) segment declined 9% year over year to $3,179 million. Retail adjusted EBITDA for the segment increased as a result of lower expenses and higher crop protection and seed margins, including enhanced proprietary product gross margins and improved margins and selling expenses in Brazil. The figure was higher than our estimate of $3,113.2 million.
The Potash division’s sales declined 31% year over year to $536 million, lower than our estimate of $709 million. Potash sales volumes fell from the previous year's record levels, owing to a more restricted fall application window in North America and fewer exports to China and other Asian countries.
Sales in the Nitrogen segment were $1,013 million, up around 6% year over year. Nitrogen sales volumes grew in the fourth quarter, owing to increasing urea production and robust regional demand for ammonia. Sales volumes grew for the full year 2024 primarily due to increased production at NTR’s Trinidad operations and reliability improvements across the North American network, which boosted the availability of upgraded products. The reported figure was lower than our estimate of $1,033.8 million.
Sales in the Phosphate segment were $414 million, down around 22% year over year. The figure was higher than our estimate of $360.1 million. Phosphate sales volumes fell in the fourth quarter and 2024, owing mostly to weather-related incidents and plant outages that reduced output volumes.
NTR’s Financials
At the end of the quarter, Nutrien had cash and cash equivalents of $853 million, down around 9.3% year over year. Long-term debt was $8,881 million, down nearly 0.3% year over year.
Cash provided by operating activities was $3,123 million in the quarter.
NTR’s FY24 Results
Nutrien reported net earnings of $1.36 earnings per share compared with $2.53 a year ago. Adjusted earnings per share were $3.47 compared with $4.44 a year ago. The company recorded total sales of around $26 billion for the year (down 11% year over year), with adjusted EBITDA reaching roughly $5.4 billion.
NTR’s Guidance
Nutrien projects Retail adjusted EBITDA in the range of $1.65-$1.85 billion for 2025. The company anticipates increased crop nutrient sales volumes, ongoing expansion of its proprietary products and additional margin recovery in Brazil. It anticipates foreign exchange headwinds in its international retail operations, as well as the lack of asset sales and other income items recognized in 2024, totaling about $75 million.
The projected potash sales volume range of 13.6-14.4 million tons is consistent with its global shipments outlook and takes into consideration some uncertainty about the potential imposition and impact of U.S. tariffs, as well as global supply availability.
Nitrogen sales volume projection of 10.7-11.2 million tons is based on sustained reliability improvements and increased operating rates at NTR’s North American operations.
The phosphate sales volume projection of 2.35-2.55 million tons implies reduced production at the company’s White Springs facility in the first half of 2025 and higher operating rates in the second half compared with the previous year.
Total capital expenditures of $2- $2.1 billion are projected to be lower than last year.
NTR’s Stock Price Performance
Nutrien’s shares have lost 1.9% in the past year compared with the industry’s 2.4% decline.
Image Source: Zacks Investment Research
NTR’s Zacks Rank & Key Picks
NTR currently carries a Zacks Rank #3 (Hold).
Better-ranked stocks worth a look in the basic materials space are ICL Group Ltd. (ICL - Free Report) , Fortuna Mining Corp. (FSM - Free Report) and Kronos Worldwide (KRO - Free Report) .
ICL is slated to report fourth-quarter results on Feb. 26. The Zacks Consensus Estimate for fourth-quarter earnings is pegged at six cents per share. ICL beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 18.1%. ICL currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Fortuna is scheduled to release fourth-quarter results on March 5. The Zacks Consensus Estimate for FSM’s fourth-quarter earnings is pegged at 16 cents per share. FSM, a Zacks Rank #2 stock, has gained around 64.6% in the past year. FSM beat the Zacks Consensus Estimate in two of the last four quarters while missing twice, with the average earnings surprise being 53.5%.
Kronos is expected to report fourth-quarter results on March 5. The consensus estimate for KRO’s fourth-quarter earnings is pegged at 11 cents per share. KRO, carrying a Zacks Rank of 2 at present, beat the consensus estimate in three of the last four quarters while missing once, with the average earnings surprise being 41.7%.